Publications
- Use of ibrutinib as "bridging" for allogeneic hematopoietic stem cell transplantation from haploidentic donor and subsequent therapy of residual disease after transplantation in a patient with highly adverse mantle cell lymphoma2019 | First Faculty of Medicine
- WT1 Gene Expression in Peripheral Blood Before and After Allogeneic Stem Cell Transplantation is a Clinically Relevant Prognostic Marker in AML - A Single-center 14-year Experience2021 | First Faculty of Medicine
- WT1 Expression in Peripheral Blood at Diagnosis and During the Course of Early Consolidation Treatment Correlates With Survival in Patients With Intermediate and Poor-Risk Acute Myeloid Leukemia2020 | First Faculty of Medicine
- Allogeneic hematopoietic cell transplantation and cellular therapy in CLL2019 | First Faculty of Medicine
- Hematopoietic Stem Cell Transplantation From Haploidentical Donors in Aplasia After Cladribine/Cytarabine Chemotherapy for Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome2019 | First Faculty of Medicine
- Efekt léčby ibrutinibem u relapsu CLL po alogenní transplantaci krvetvorných buněk2017 | First Faculty of Medicine
- Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients2013 | First Faculty of Medicine
- The current role of haematopoietic stem cell transplantation in the treatment of lymphomas : review2010 | First Faculty of Medicine
- The impact of CD34+ selection on the outcome high dose therapy with autologous stem cell transplantation in lymphoma patients2001 | First Faculty of Medicine
- The impact of CD34+ selection on the outcome high dose therapy with autologous stem cell transplantation in lymphoma patients2001 | Faculty of Physical Education and Sport
Loading network view...